Sai Next Medicate Ailment LLP
About Sai Next Medicate Ailment LLP
Data last updated:
Sai Next Medicate Ailment LLP was a limited liability partnership (LLP) based in New Delhi, Delhi, India. The LLP has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the service-based operations segment of the business services sector. It was incorporated on 24 April 2015.
The LLP was registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAD-8219.
The LLP had a total obligation of contribution of ₹1 Lakh. It was led by designated partners Amrit Varsha Datta and Sumit Kumar Datta.
Its latest statement of accounts is for the year ended 31 March 2018. The registered office was at C – 106 Lal Qtrs Punjabi Bagh, New Delhi, Delhi, India – 110026.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC – 106 Lal Qtrs Punjabi Bagh, New Delhi, Delhi, India – 110026
- IndustryBusiness Services, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Sai Next Medicate Ailment LLP FY 2018 filings available
Financial Statement Summary of Sai Next Medicate Ailment LLP
| Statement of Account and Solvency | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|
| Income and Expenditure | |||
| Turnover | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• |
| Assets and Liabilities | |||
| Partners' Contribution | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Sai Next Medicate Ailment LLP
| Statement of Account and Solvency | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|
| Profitability | |||
| Net Profit Margin | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Sai Next Medicate Ailment are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Sai Next Medicate Ailment LLP
Sai Next Medicate Ailment has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amrit Varsha Datta | Designated Partner | 24 Apr 2015 | 11 Years 5 Months | As last reported |
| Sumit Kumar Datta | Designated Partner | 24 Apr 2015 | 11 Years 5 Months | As last reported |
Charges & Borrowings of Sai Next Medicate Ailment LLP
Sai Next Medicate Ailment LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Sai Next Medicate Ailment LLP
Employment history and EPFO contributions of people linked to Sai Next Medicate Ailment.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sai Next Medicate Ailment LLP
Sai Next Medicate Ailment LLP has 2 designated partner changes on record since 2015: 2 appointments. The latest: Amrit Varsha Datta was appointed as Designated Partner on 24 Apr 2015.
Credit Ratings, Litigation & Regulatory Alerts for Sai Next Medicate Ailment LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sai Next Medicate Ailment LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sai Next Medicate Ailment LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sai Next Medicate Ailment LLP
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sai Next Medicate Ailment LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sai Next Medicate Ailment LLP
Sai Next Medicate Ailment has a status of "Struck Off" as per MCA records. This means the LLP has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off LLP cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Sai Next Medicate Ailment was a limited liability partnership based in New Delhi, Delhi, India. The LLP worked in other services, within the business services industry. It was incorporated on 24 April 2015 and is registered under LLPIN AAD-8219. The LLP has been struck off by the Registrar of Companies and is no longer operational.
Sai Next Medicate Ailment had 2 designated partners:
- Amrit Varsha Datta - Designated Partner
- Sumit Kumar Datta - Designated Partner
The LLPIN (Limited Liability Partnership Identification Number) of Sai Next Medicate Ailment is AAD-8219. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
The registered office of Sai Next Medicate Ailment is at C – 106 Lal Qtrs Punjabi Bagh, New Delhi, Delhi, India – 110026.
Sai Next Medicate Ailment was incorporated on 24 April 2015. It is registered with the Registrar of Companies, Delhi.
The total obligation of contribution is ₹1 Lakh.
Sai Next Medicate Ailment operated in the business services industry, in the other services segment. It worked in this industry before it was struck off.
Amrit Varsha Datta was appointed as Designated Partner on 24 Apr 2015. Sumit Kumar Datta was appointed as Designated Partner on 24 Apr 2015.
Sai Next Medicate Ailment can be reached at its registered office: C – 106 Lal Qtrs Punjabi Bagh, New Delhi, Delhi, India – 110026.